BAJAJ BROKING

Notification
No new Notification messages
Chamunda Electrical Ltd IPO is Open!
Apply for the Chamunda Electrical Ltd IPO through UPI in just minutes.
Q3 FY'25 Results of Top Companies!
From Reliance Industries to TCS to HDFC Bank, check out the latest quarterly results with financial highlights, key performance metrics, and more!
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Amwill Healthcare IPO: Things Smart Investors Need to Know

Amwill Health Care Limited, founded in August 2017, is a company that focuses on developing derma-cosmetic products in collaboration with contract manufacturers, distributors, and third-party product development agencies. This partnership approach has enabled the company to enhance its capabilities in manufacturing, packaging, and distribution. Amwill Health Care's product range is divided into two categories: the development of generic dermatological solutions and the formulation of targeted solutions to address specific skin issues. The company primarily operates in Karnataka, Andhra Pradesh, and Telangana, aiming to build a strong customer base before expanding into new markets.

The company offers products that target various dermatological conditions, such as acne, fungal infections, anti-aging, and vitiligo, among others. As of September 2024, Amwill Health Care has 84 employees and relies on third-party agencies for manufacturing, prototype development, and distribution to streamline operations. Most of its products were developed by Anand Gandhi, the company's Promoter and Managing Director, who previously operated as a sole proprietor under M/s. Amwill Healthcare.

For more details, visit the Amwill Health Care IPO page.

Amwill Health Care IPO Details and Objectives

Details

Information

IPO Date

February 5, 2025 to February 7, 2025

Issue Size

54,03,600 shares

(aggregating up to ₹59.98 Cr)

Price Band

₹105 to ₹111 per share

Lot Size

1,200 shares

Listing At

BSE SME

Market Maker

Globalworth Securities Limited

Purpose of the IPO

  • Financing working capital needs
  • Marketing and brand development
  • General corporate purposes

Timeline of Amwill Health Care IPO

Event

Date

IPO Open Date

Wednesday, February 5, 2025

IPO Close Date

Friday, February 7, 2025

Basis of Allotment

Monday, February 10, 2025

Initiation of Refunds

Tuesday, February 11, 2025

Credit of Shares to Demat

Tuesday, February 11, 2025

Listing Date

Wednesday, February 12, 2025

Cut-off time for UPI mandate confirmation

5 PM on February 7, 2025

Pricing & Lot Size of Amwill Health Care IPO

Price Band for the IPO

●        ₹105 to ₹111 per share

Minimum Lot Size and Application Details

Application

Lots

Shares

Amount

Retail (Min)

1

1200

₹1,33,200

Retail (Max)

1

1200

₹1,33,200

HNI (Min)

2

2,400

₹2,66,400

How to Apply for the Amwill Health Care IPO?

Online Application Process

  • Log in to Your Trading Account

    Access your trading account through your broker’s platform.

  • Navigate to the IPO Section

    Go to the IPO section to view active IPO listings.

  • Select Amwill Health Care IPO

    Find "Amwill Health Care IPO" and click on the ‘Apply’ button.

  • Enter Application Details

    Specify the number of lots (minimum lot size: 1,200 shares) and the bid price within the range of ₹105 to ₹111 per share.

  • Provide Your UPI ID

    Enter your UPI ID for payment authorization. Ensure that sufficient funds are available in your linked account.

  • Review and Submit

    Verify all the details entered before submitting the application. Approve the UPI mandate before 5 PM on February 7, 2025, to complete your application process.

Financial Health and Performance

Key Financial Metrics

  • Total Assets: Grew from ₹6.59 crore in FY22 to ₹28.89 crore as of September 2024.
  • Revenue: Reached ₹23.25 crore in FY24.
  • Profit After Tax (PAT): Stood at ₹6.52 crore for September 2024.
  • Net Worth: Increased from ₹1.49 crore in FY22 to ₹23.68 crore as of September 2024.
  • Reserves and Surplus: Recorded at ₹8.08 crore (Sept 2024), growing steadily over the years.

Recent Performance and Growth Prospects

  • Significant growth in total assets, reflecting the company’s expanding financial strength.
  • Revenue has experienced a substantial increase, highlighting positive business performance.
  • Profit after tax (PAT) shows healthy growth, indicating efficient operational management.
  • Net worth has notably increased, underscoring the company’s financial stability and value creation.
  • Reserves and surplus have grown steadily, ensuring long-term financial security and support for future initiatives.

Investment Risks and Opportunities

Potential Risks of Investing in the IPO

  • Reliance on third-party contract manufacturers and distributors may expose the company to supply chain disruptions, potentially affecting product availability and delivery timelines.
  • The company operates primarily in a limited number of regions, and expansion into new markets may present challenges due to regional competition, consumer behaviour differences, and regulatory hurdles.

Opportunities and Growth Potential

  • Amwill Health Care’s focus on innovative derma-cosmetic solutions tailored to specific dermatological issues provides significant growth opportunities in the expanding beauty and personal care market.
  • With a growing portfolio of targeted products and an increasing market presence in Southern India, the company has a strong foundation to expand its customer base and enter new regions in the future.

Key Performance Indicator (KPI)

KPI

Values

ROE

19.90%

ROCE

51.52%

Debt/Equity

0.09

RoNW

19.90%

PAT Margin

2.22

Price to Book Value

3.85

Amwill Health Care IPO Registrar & Lead Managers

Registrar

Lead Manager(s)

Skyline Financial Services Private Ltd

Corporate Makers Capital Ltd.

Company Address of Amwill Health Care Ltd

Amwill Healthcare Limited

No. 157, 1st Floor,

2nd Main, r, 2nd Main, 3rd Cross Chamrajpet

Bangalore – 560018

Phone: +91 8043026281

Email: amwill@amwillhealthcare.com

Website: https://www.amwillhealthcare.com/

Conclusion

In conclusion, Amwill Health Care Limited, established in 2017, has positioned itself in the derma-cosmetic industry with a focus on developing targeted skincare solutions. The company's collaboration with third-party manufacturers and distributors has helped streamline its operations and expand its product range. With a presence primarily in Karnataka, Andhra Pradesh, and Telangana, Amwill aims to strengthen its foundation before venturing into new markets.

As it moves forward with its IPO, the company seeks to finance working capital, marketing, and corporate objectives. While the business shows growth potential in the dermatological space, there are risks tied to its reliance on external partners and regional market expansion. The future of Amwill Health Care will depend on how well it navigates these factors while continuing to build its customer base and financial position.

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Amwill Health Care IPO.  

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://bit.ly/3Tcsfuc

Share this article: 

Frequently Asked Questions

Who is the CEO of Amwill Health Care Ltd?

Answer Field

Amwill Health Care Ltd. is led by its Promoter and Managing Director, Anand Gandhi. 

What is the company’s core business, and how sustainable is its business model in the long term?

Answer Field

Amwill Health Care Ltd. focuses on developing derma-cosmetic products for various dermatological conditions. The company collaborates with third-party manufacturers and distributors to streamline operations. The sustainability of its business model depends on its ability to innovate in the competitive skincare market and expand to new regions successfully.

What is the issue size of the Amwill Healthcare SME IPO?

Answer Field

The issue size of the Amwill Healthcare SME IPO is 54,03,600 shares, aggregating up to ₹59.98 crore.

What is pre-apply for the Amwill Healthcare SME IPO?

Answer Field

'Pre-apply' is a term referring to the process of expressing interest or submitting an order for the IPO before the actual subscription period begins. This allows investors to be ready for the official subscription and allotment process.

When will I know if my Amwill Healthcare IPO order is placed?

Answer Field

You will know if your order for the Amwill Healthcare IPO is placed after the Basis of Allotment date, which is February 10, 2025.

What is the lot size and minimum order quantity of the Amwill Healthcare IPO?

Answer Field

The lot size for the Amwill Healthcare IPO is 1,200 shares.

What is the allotment date for the Amwill Healthcare SME IPO?

Answer Field

The allotment date for the Amwill Healthcare SME IPO is February 10, 2025.

Who is the registrar of Amwill Healthcare IPO?

Answer Field

The registrar for the Amwill Healthcare IPO is Skyline Financial Services Private Ltd.

Are there any governance issues or red flags in the company’s leadership or board structure?

Answer Field

Based on the available information, there are no significant governance issues or red flags mentioned regarding the leadership or board structure of Amwill Health Care Ltd.

No Result Found

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5300+ Cr MTF Book

icon-with-text